First-line doublet immunotherapy: Game changer or hype for patients with mesothelioma?

Saved in:
Bibliographic Details
Published in:Lung cancer (Amsterdam, Netherlands) Netherlands), 2024-08, Vol.194, p.107891, Article 107891
Main Authors: Douma, L.H., Baas, P., de Gooijer, C.J.
Format: Article
Language:English
Subjects:
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Humans
Immune Checkpoint Inhibitors - therapeutic use
Immunotherapy - methods
Lung Neoplasms - therapy
Mesothelioma - immunology
Mesothelioma - therapy
Mesothelioma, Malignant - therapy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0169-5002
1872-8332
1872-8332
DOI:10.1016/j.lungcan.2024.107891